IRIS
LOCATI, LAURA DEBORAH
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.500
NA - Nord America 1.191
EU - Europa 812
SA - Sud America 240
AF - Africa 67
OC - Oceania 3
Totale 3.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.112
SG - Singapore 465
CN - Cina 377
HK - Hong Kong 265
RU - Federazione Russa 216
VN - Vietnam 190
BR - Brasile 171
FR - Francia 143
DE - Germania 132
IT - Italia 123
GB - Regno Unito 62
IN - India 55
MX - Messico 41
ZA - Sudafrica 34
FI - Finlandia 32
CA - Canada 28
AR - Argentina 25
BD - Bangladesh 24
PL - Polonia 22
TR - Turchia 16
IQ - Iraq 14
ES - Italia 13
AT - Austria 11
IE - Irlanda 11
JP - Giappone 11
PK - Pakistan 10
CO - Colombia 9
EC - Ecuador 9
UZ - Uzbekistan 9
VE - Venezuela 9
ID - Indonesia 8
MY - Malesia 8
NL - Olanda 8
SA - Arabia Saudita 8
CL - Cile 7
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
NO - Norvegia 5
PH - Filippine 5
SE - Svezia 5
CZ - Repubblica Ceca 4
JO - Giordania 4
KZ - Kazakistan 4
PY - Paraguay 4
TN - Tunisia 4
AZ - Azerbaigian 3
BE - Belgio 3
ET - Etiopia 3
JM - Giamaica 3
NP - Nepal 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KE - Kenya 2
LV - Lettonia 2
QA - Qatar 2
UA - Ucraina 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 3.813
Salva come PNG Salva come JPEG
Città #
Hong Kong 260
San Jose 229
Singapore 227
Dallas 176
Ashburn 123
Beijing 114
Los Angeles 73
Lauterbourg 71
Hanoi 55
Ho Chi Minh City 52
Munich 50
Redondo Beach 49
Moscow 35
New York 30
Falkenstein 28
Johannesburg 28
Mexico City 28
Turku 28
Santa Clara 25
Buffalo 24
Milan 23
Orem 22
São Paulo 21
Warsaw 18
Frankfurt am Main 17
Montreal 16
Shanghai 16
Haiphong 15
Brooklyn 14
Chennai 14
Nuremberg 14
Denver 12
London 12
Changsha 11
Dublin 11
Guangzhou 11
Pavia 11
Secaucus 11
Atlanta 10
Boardman 10
Da Nang 10
Tokyo 10
Yiwu 10
Chicago 9
Council Bluffs 9
Seattle 9
Tashkent 9
Hyderabad 8
Phoenix 8
Rome 8
Dhaka 7
Düsseldorf 7
Novate Milanese 7
Charlotte 6
Houston 6
Kuala Lumpur 6
New Delhi 6
Amsterdam 5
Ankara 5
Belo Horizonte 5
Boston 5
Brasília 5
Bến Tre 5
Elk Grove Village 5
Madrid 5
Manchester 5
Paris 5
Poplar 5
Riyadh 5
Stockholm 5
Almaty 4
Amman 4
Baghdad 4
Curitiba 4
Guayaquil 4
Helena 4
Helsinki 4
Mumbai 4
San Francisco 4
Vienna 4
Addis Ababa 3
Baku 3
Bắc Ninh 3
Campinas 3
Can Tho 3
Dakar 3
Desio 3
Honolulu 3
Kingston 3
Montevideo 3
Nha Trang 3
Ninh Bình 3
Pittsburgh 3
Porto Alegre 3
Quito 3
Thái Bình 3
Toronto 3
Turin 3
Ulyanovsk 3
Vĩnh Tường 3
Totale 2.294
Salva come PNG Salva come JPEG
Nome #
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 143
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial 119
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 80
Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study 75
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 74
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination 73
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 73
A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient 72
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 69
Vitamin B12 status in hospitalised cancer patients: Prevalence and clinical implications of depletion and hypervitaminosis 68
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor–Expressing Salivary Gland Cancer: A Phase II Trial 65
NR4A3 fusion molecular profile change pathological diagnosis? A case report 65
Please mind the gap-about equity and access to care in oncology 65
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma 62
Charged particle radiotherapy for thyroid cancer. A systematic review 62
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 60
Adenoid Cystic carcinoma of minor salivary glands (AdCCmSG): a multidisciplinary update 57
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 56
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer 55
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 53
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 52
Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up 52
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 51
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area 50
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 49
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 49
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 49
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 48
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 47
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 47
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 47
Current picture of anaplastic thyroid cancer patients' care and meetable needs: A survey of 94 Institutions from the EORTC Endocrine and Head and Neck Cancer Groups 46
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 45
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 45
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 45
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 45
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study 45
Salivary gland cancers in elderly patients: challenges and therapeutic strategies 44
Major and minor salivary gland tumours 43
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 42
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 42
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 42
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 42
International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34 41
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells 41
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 41
Exposure to Occupational Carcinogens and Non-Oncogene Addicted Phenotype in Lung Cancer: Results from a Real-Life Observational Study 40
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 40
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer 39
How can we address the challenge of distant metastases in HNSCC prognosis? 39
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 39
An Old but Still Unanswered Question in Recurrent or Metastatic Salivary Duct Carcinoma 39
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe 38
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 38
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma 38
Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck 38
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 37
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy 36
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 36
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 36
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 36
The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients 35
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 35
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet) 34
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 34
Current landscape and support for practical initiation of oncological prehabilitation translatable to thyroid cancer: A position paper 33
Current management and future challenges in salivary glands cancer 33
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer 33
Rare Head and Neck Cancers and Pathological Diagnosis Challenges: A Comprehensive Literature Review 33
A novel interface terminology for patient-reported outcomes in home patients monitoring applications 30
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 30
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 29
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 29
Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer 28
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 27
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience 27
Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer 27
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities? 26
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice 26
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 25
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma 23
Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma 23
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 22
Assessing Effective Engagement with Digital Behavior Change Intervention: The Case Study of the CAPABLE Project 21
Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma 21
Malignant salivary gland tumours in families with breast cancer susceptibility 20
Totale 3.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 1 0 0 0 2
2022/202315 1 0 0 0 1 1 0 0 10 0 2 0
2023/202461 1 6 0 1 1 4 10 3 5 2 11 17
2024/20251.171 9 14 21 18 13 179 104 87 264 46 112 304
2025/20262.659 225 211 222 388 364 132 467 138 293 219 0 0
Totale 3.909